Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) was up 28.6% during trading on Monday . The stock traded as high as C$0.21 and last traded at C$0.18. Approximately 1,188,155 shares changed hands during trading, an increase of 253% from the average daily volume of 336,778 shares. The stock had previously closed at C$0.14.
Voyageur Pharmaceuticals Price Performance
The business’s 50-day simple moving average is C$0.08 and its two-hundred day simple moving average is C$0.06. The stock has a market cap of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Why Invest in High-Yield Dividend Stocks?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- 3 Stocks to Consider Buying in October
- Delta Can Fly to New Highs in 2025; Here’s Why
- Short Selling – The Pros and Cons
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
